622 related articles for article (PubMed ID: 24495589)
21. Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years.
Strode M; Shah R; Boland PM; Francescutti VA; Mangieri CW; Attwood K; Nurkin SJ
Surg Oncol; 2019 Mar; 28():116-120. PubMed ID: 30851884
[TBL] [Abstract][Full Text] [Related]
22. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
[TBL] [Abstract][Full Text] [Related]
23. Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response.
Habr-Gama A; São Julião GP; Gama-Rodrigues J; Vailati BB; Ortega C; Fernandez LM; Araújo SEA; Perez RO
Dis Colon Rectum; 2017 Jun; 60(6):586-594. PubMed ID: 28481852
[TBL] [Abstract][Full Text] [Related]
24. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
Dattani M; Heald RJ; Goussous G; Broadhurst J; São Julião GP; Habr-Gama A; Perez RO; Moran BJ
Ann Surg; 2018 Dec; 268(6):955-967. PubMed ID: 29746338
[TBL] [Abstract][Full Text] [Related]
25. Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).
Wang L; Zhang XY; Zhao YM; Li SJ; Li ZW; Sun YS; Wang WH; Wu AW;
Ann Surg; 2023 Apr; 277(4):647-654. PubMed ID: 35766394
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
27. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
Wang QX; Zhang R; Xiao WW; Zhang S; Wei MB; Li YH; Chang H; Xie WH; Li LR; Ding PR; Chen G; Zeng ZF; Wang WH; Wan XB; Gao YH
Radiat Oncol; 2021 Jan; 16(1):16. PubMed ID: 33468176
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and meta-analysis on outcomes of salvage therapy in patients with tumour recurrence during 'watch and wait' in rectal cancer.
On J; Shim J; Aly EH
Ann R Coll Surg Engl; 2019 Sep; 101(7):441-452. PubMed ID: 30855163
[TBL] [Abstract][Full Text] [Related]
29. [Waiting ("Watch and Wait") for complete clinical remission after neoadjuvant radiochemotherapy of rectal carcinomas: influence of salvage-therapy on local tumor control].
Hohenberger W
Strahlenther Onkol; 2014 Jul; 190(7):692-3. PubMed ID: 25061654
[No Abstract] [Full Text] [Related]
30. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
[TBL] [Abstract][Full Text] [Related]
31. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
[TBL] [Abstract][Full Text] [Related]
32. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
[TBL] [Abstract][Full Text] [Related]
33. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
[TBL] [Abstract][Full Text] [Related]
34. Low rectal cancer treatment strategies: a cohort study assessing watch and wait.
Pinto JC; Pereira AD; Pimenta A; Pedro C; Fernandez G; Marques I; Miguel I; Freire J; Maciel J; Venâncio J; D'Orey L; Mirones L; Limbert M; Labareda M; Chaves P; Fonseca R; Barroca R; Ferreira T; Marques T; Rosa I
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2631-2638. PubMed ID: 32435893
[TBL] [Abstract][Full Text] [Related]
35. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
Li J; Liu H; Yin J; Liu S; Hu J; Du F; Yuan J; Lv B; Fan J; Leng S; Zhang X
Oncotarget; 2015 Dec; 6(39):42354-61. PubMed ID: 26472284
[TBL] [Abstract][Full Text] [Related]
36. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
[TBL] [Abstract][Full Text] [Related]
37. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.
Habr-Gama A; Perez RO; Proscurshim I; Campos FG; Nadalin W; Kiss D; Gama-Rodrigues J
J Gastrointest Surg; 2006 Dec; 10(10):1319-28; discussion 1328-9. PubMed ID: 17175450
[TBL] [Abstract][Full Text] [Related]
38. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
[TBL] [Abstract][Full Text] [Related]
39. [Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer].
Zhao MH; Sun TT; Wang L; Huang YL; Xie XY; Lu Y; Zhao GH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):383-394. PubMed ID: 38644244
[No Abstract] [Full Text] [Related]
40. Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.
Madbouly KM; Hussein AM
World J Surg; 2015 May; 39(5):1248-56. PubMed ID: 25561197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
